Skip to main content
Top
Published in: Critical Care 5/2013

Open Access 01-10-2013 | Research

Kinetics of circulating immunoglobulin M in sepsis: relationship with final outcome

Authors: Evangelos J Giamarellos-Bourboulis, Efterpi Apostolidou, Malvina Lada, Ioannis Perdios, Nikolaos K Gatselis, Iraklis Tsangaris, Marianna Georgitsi, Magdalini Bristianou, Theodora Kanni, Kalliopi Sereti, Miltiades A Kyprianou, Anastasia Kotanidou, Apostolos Armaganidis

Published in: Critical Care | Issue 5/2013

Login to get access

Abstract

Introduction

The aim of this study was to investigate the kinetics of immunoglobulin M (IgM) during the different stages of sepsis.

Methods

In this prospective multicenter study, blood sampling for IgM measurement was done within the first 24 hours from diagnosis in 332 critically ill patients; in 83 patients this was repeated upon progression to more severe stages. Among these 83 patients, 30 patients with severe sepsis progressed into shock and IgM was monitored daily for seven consecutive days. Peripheral blood mononuclear cells (PBMCs) were isolated from 55 patients and stimulated for IgM production.

Results

Serum IgM was decreased in septic shock compared to patients with systemic inflammatory response syndrome (SIRS) and patients with severe sepsis. Paired comparisons at distinct time points of the sepsis course showed that IgM was decreased only when patients deteriorated from severe sepsis to septic shock. Serial measurements in these patients, beginning from the early start of vasopressors, showed that the distribution of IgM over time was significantly greater for survivors than for non-survivors. Production of IgM by PBMCs was significantly lower at all stages of sepsis compared with healthy controls.

Conclusions

Specific changes of circulating IgM occur when patients with severe sepsis progress into septic shock. The distribution of IgM is lower among non-survivors.
Appendix
Available only for authorised users
Literature
1.
go back to reference Giamarellos-Bourboulis EJ, Raftogiannis M: The immune response to severe bacterial infections: consequences for therapy. Expert Rev Anti Infect Ther. 2012, 10: 369-380. 10.1586/eri.12.2.CrossRefPubMed Giamarellos-Bourboulis EJ, Raftogiannis M: The immune response to severe bacterial infections: consequences for therapy. Expert Rev Anti Infect Ther. 2012, 10: 369-380. 10.1586/eri.12.2.CrossRefPubMed
2.
go back to reference Boomer JS, To K, Chang KC, Takasu O, Osborne DF, Walton AH, Bricker TL, Jarman SD, Kreisel D, Krupnick AS, Srivastava A, Swanson PE, Green JM, Hotchkiss RS: Immunosuppression in patients who die of sepsis and multiple organ failure. JAMA. 2011, 306: 2594-2605. 10.1001/jama.2011.1829.PubMedCentralCrossRefPubMed Boomer JS, To K, Chang KC, Takasu O, Osborne DF, Walton AH, Bricker TL, Jarman SD, Kreisel D, Krupnick AS, Srivastava A, Swanson PE, Green JM, Hotchkiss RS: Immunosuppression in patients who die of sepsis and multiple organ failure. JAMA. 2011, 306: 2594-2605. 10.1001/jama.2011.1829.PubMedCentralCrossRefPubMed
4.
go back to reference Kreymann KG, de Heer G, Nierhaus A, Kluge S: Use of polyclonal immunoglobulins as adjunctive therapy for sepsis or septic shock. Crit Care Med. 2007, 35: 2677-2685. 10.1097/01.CCM.0000295263.12774.97.CrossRefPubMed Kreymann KG, de Heer G, Nierhaus A, Kluge S: Use of polyclonal immunoglobulins as adjunctive therapy for sepsis or septic shock. Crit Care Med. 2007, 35: 2677-2685. 10.1097/01.CCM.0000295263.12774.97.CrossRefPubMed
5.
go back to reference Laupland KB, Kirkpatrick AW, Delaney A: Polyclonal intravenous immunoglobulin for the treatment of severe sepsis and septic shock in critically ill adults: a systematic review and meta-analysis. Crit Care Med. 2007, 35: 2686-2692. 10.1097/01.CCM.0000295312.13466.1C.CrossRefPubMed Laupland KB, Kirkpatrick AW, Delaney A: Polyclonal intravenous immunoglobulin for the treatment of severe sepsis and septic shock in critically ill adults: a systematic review and meta-analysis. Crit Care Med. 2007, 35: 2686-2692. 10.1097/01.CCM.0000295312.13466.1C.CrossRefPubMed
6.
go back to reference Levy M, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G: 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. Crit Care Med. 2003, 31: 1250-1256. 10.1097/01.CCM.0000050454.01978.3B.CrossRefPubMed Levy M, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G: 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. Crit Care Med. 2003, 31: 1250-1256. 10.1097/01.CCM.0000050454.01978.3B.CrossRefPubMed
7.
8.
go back to reference Christ-Crain M, Stolz D, Bingisser R, Müller C, Miedinger D, Huber PR, Zimmerli W, Harbath S, Tamm M, Müller B: Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia. A randomized trial. Am J Resp Crit Care Med. 2006, 174: 84-93. 10.1164/rccm.200512-1922OC.CrossRefPubMed Christ-Crain M, Stolz D, Bingisser R, Müller C, Miedinger D, Huber PR, Zimmerli W, Harbath S, Tamm M, Müller B: Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia. A randomized trial. Am J Resp Crit Care Med. 2006, 174: 84-93. 10.1164/rccm.200512-1922OC.CrossRefPubMed
9.
go back to reference Rello J, Paiva JA, Baraibar J, Barcenilla F, Bodi M, Castander D, Correa H, Diaz E, Garnacho J, Llorio M, Rios M, Rodriguez A, Solé-Violán J: International conference for the development of consensus on the diagnosis and treatment of ventilator-associated pneumonia. Chest. 2001, 120: 955-970. 10.1378/chest.120.3.955.CrossRefPubMed Rello J, Paiva JA, Baraibar J, Barcenilla F, Bodi M, Castander D, Correa H, Diaz E, Garnacho J, Llorio M, Rios M, Rodriguez A, Solé-Violán J: International conference for the development of consensus on the diagnosis and treatment of ventilator-associated pneumonia. Chest. 2001, 120: 955-970. 10.1378/chest.120.3.955.CrossRefPubMed
10.
go back to reference Pinson AG, Philbrick JT, Lindbeck GH, Schorling JB: Fever in the clinical diagnosis of acute pyelonephritis. Am J Emerg Med. 1997, 15: 148-151. 10.1016/S0735-6757(97)90087-5.CrossRefPubMed Pinson AG, Philbrick JT, Lindbeck GH, Schorling JB: Fever in the clinical diagnosis of acute pyelonephritis. Am J Emerg Med. 1997, 15: 148-151. 10.1016/S0735-6757(97)90087-5.CrossRefPubMed
11.
go back to reference Calandra T, Cohen J: The international sepsis forum consensus conference definitions of infections in the intensive care unit. Crit Care Med. 2005, 33: 1539-1548.CrossRef Calandra T, Cohen J: The international sepsis forum consensus conference definitions of infections in the intensive care unit. Crit Care Med. 2005, 33: 1539-1548.CrossRef
12.
go back to reference Gogos C, Kotsaki A, Pelekanou A, Giannikopoulos G, Vaki I, Maravitsa P, Adamis S, Alexiou Z, Andrianopoulos G, Antonopoulou A, Athanassia S, Baziaka F, Charalambous A, Christodoulou S, Dimopoulou I, Floros I, Giannitsioti E, Gkanas P, Ioakeimidou A, Kanellakopoulou K, Karabela N, Karagianni V, Katsarolis I, Kontopithari G, Kopterides P, Koutelidakis I, Koutoukas P, Kranidioti H, Lignos M, Louis K, et al: Early alterations of the innate and adaptive immune statuses in sepsis according to the type of underlying infection. Crit Care. 2010, 14: R96-10.1186/cc9031.PubMedCentralCrossRefPubMed Gogos C, Kotsaki A, Pelekanou A, Giannikopoulos G, Vaki I, Maravitsa P, Adamis S, Alexiou Z, Andrianopoulos G, Antonopoulou A, Athanassia S, Baziaka F, Charalambous A, Christodoulou S, Dimopoulou I, Floros I, Giannitsioti E, Gkanas P, Ioakeimidou A, Kanellakopoulou K, Karabela N, Karagianni V, Katsarolis I, Kontopithari G, Kopterides P, Koutelidakis I, Koutoukas P, Kranidioti H, Lignos M, Louis K, et al: Early alterations of the innate and adaptive immune statuses in sepsis according to the type of underlying infection. Crit Care. 2010, 14: R96-10.1186/cc9031.PubMedCentralCrossRefPubMed
13.
go back to reference Livaditi O, Giamarellos-Bourboulis EJ, Kakkas I, Kaspimali V, Lymberi P, Papasteriades C, Douzinas E: Grouping of patients with common variable immunodeficiency based on immunoglobulin biosynthesis: comparison with a classification system on CD4-naïve cells. Immunol Lett. 2007, 114: 103-109. 10.1016/j.imlet.2007.09.006.CrossRefPubMed Livaditi O, Giamarellos-Bourboulis EJ, Kakkas I, Kaspimali V, Lymberi P, Papasteriades C, Douzinas E: Grouping of patients with common variable immunodeficiency based on immunoglobulin biosynthesis: comparison with a classification system on CD4-naïve cells. Immunol Lett. 2007, 114: 103-109. 10.1016/j.imlet.2007.09.006.CrossRefPubMed
14.
go back to reference Taccone PS, Stordeur P, De Backer D, Creteur J, Vincent JL: γ-globulin levels in patients with community-acquired septic shock. Shock. 2009, 32: 379-385. 10.1097/SHK.0b013e3181a2c0b2.CrossRefPubMed Taccone PS, Stordeur P, De Backer D, Creteur J, Vincent JL: γ-globulin levels in patients with community-acquired septic shock. Shock. 2009, 32: 379-385. 10.1097/SHK.0b013e3181a2c0b2.CrossRefPubMed
15.
go back to reference Venet F, Gebeile R, Bancel J, Guignant C, Poitevin-Later F, Malcus C, Lepape A, Monneret G: Assessment of plasmatic immunoglobulin G, A and M levels in septic shock patients. Int Immunopharmacol. 2011, 11: 2086-2090. 10.1016/j.intimp.2011.08.024.CrossRefPubMed Venet F, Gebeile R, Bancel J, Guignant C, Poitevin-Later F, Malcus C, Lepape A, Monneret G: Assessment of plasmatic immunoglobulin G, A and M levels in septic shock patients. Int Immunopharmacol. 2011, 11: 2086-2090. 10.1016/j.intimp.2011.08.024.CrossRefPubMed
16.
go back to reference Moitra R, Beal DR, Belikoff BG, Remick DG: Presence of pre-existing antibodies mediate survival in sepsis. Shock. 2012, 37: 56-62. 10.1097/SHK.0b013e3182356f3e.PubMedCentralCrossRefPubMed Moitra R, Beal DR, Belikoff BG, Remick DG: Presence of pre-existing antibodies mediate survival in sepsis. Shock. 2012, 37: 56-62. 10.1097/SHK.0b013e3182356f3e.PubMedCentralCrossRefPubMed
17.
go back to reference Rauch PJ, Chudnoskiy A, Robbins CS, Webe GF, Etzodt M, Hilgendorf I, Tiglao E, Figueiredo JL, Iwamoto Y, Theurl I, Gorbatov R, Waring MT, Chicoine AT, Mouded M, Pittet MJ, Nahrendorf M, Wessleder R, Swirski FK: Innate response activator B cells protect against microbial sepsis. Science. 2012, 335: 597-601. 10.1126/science.1215173.PubMedCentralCrossRefPubMed Rauch PJ, Chudnoskiy A, Robbins CS, Webe GF, Etzodt M, Hilgendorf I, Tiglao E, Figueiredo JL, Iwamoto Y, Theurl I, Gorbatov R, Waring MT, Chicoine AT, Mouded M, Pittet MJ, Nahrendorf M, Wessleder R, Swirski FK: Innate response activator B cells protect against microbial sepsis. Science. 2012, 335: 597-601. 10.1126/science.1215173.PubMedCentralCrossRefPubMed
Metadata
Title
Kinetics of circulating immunoglobulin M in sepsis: relationship with final outcome
Authors
Evangelos J Giamarellos-Bourboulis
Efterpi Apostolidou
Malvina Lada
Ioannis Perdios
Nikolaos K Gatselis
Iraklis Tsangaris
Marianna Georgitsi
Magdalini Bristianou
Theodora Kanni
Kalliopi Sereti
Miltiades A Kyprianou
Anastasia Kotanidou
Apostolos Armaganidis
Publication date
01-10-2013
Publisher
BioMed Central
Published in
Critical Care / Issue 5/2013
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/cc13073

Other articles of this Issue 5/2013

Critical Care 5/2013 Go to the issue